These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8457980)

  • 21. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215
    [No Abstract]   [Full Text] [Related]  

  • 23. Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.
    Pollack M; Ohl CA
    Curr Top Microbiol Immunol; 1996; 216():275-97. PubMed ID: 8791745
    [No Abstract]   [Full Text] [Related]  

  • 24. Endotoxemia and gram-negative bacteremia in swine: chemical mediators and therapeutic considerations.
    Olson NC; Dodam JR; Kruse-Elliott KT
    J Am Vet Med Assoc; 1992 Jun; 200(12):1884-93. PubMed ID: 1639693
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.
    Johnson MT; Reichley R; Hoppe-Bauer J; Dunne WM; Micek S; Kollef M
    Crit Care Med; 2011 Aug; 39(8):1859-65. PubMed ID: 21499086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin removal devices for the treatment of sepsis and septic shock.
    Davies B; Cohen J
    Lancet Infect Dis; 2011 Jan; 11(1):65-71. PubMed ID: 21183148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Septic shock with purpura fulminans after a dog bite].
    Völl K; Haase G; Fritz H; Riebe J; Huszka C; Kindler J
    Dtsch Med Wochenschr; 2007 Jun; 132(24):1321-4. PubMed ID: 17551886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal adsorbent-based strategies in sepsis.
    Jaber BL; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S44-56. PubMed ID: 9372979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gram-negative septicemia and shock.
    Craig CP
    Compr Ther; 1982 Feb; 8(2):13-8. PubMed ID: 7067384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gram-negative bacterial sepsis in hospitals in the United States--natural history in the 1980s.
    Martin MA; Wenzel RP; Gorelick KJ
    Prog Clin Biol Res; 1991; 367():111-9. PubMed ID: 1924421
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.
    Periti P; Mazzei T
    Int J Antimicrob Agents; 1999 Jul; 12(2):97-105. PubMed ID: 10418753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
    Bone RC; Balk RA; Fein AM; Perl TM; Wenzel RP; Reines HD; Quenzer RW; Iberti TJ; Macintyre N; Schein RM
    Crit Care Med; 1995 Jun; 23(6):994-1006. PubMed ID: 7774238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal sepsis requiring mechanical ventilation: Cohort study in 38 patients with rapid progression to septic shock.
    Ursin Rein P; Jacobsen D; Ormaasen V; Dunlop O
    Acta Anaesthesiol Scand; 2018 Nov; 62(10):1428-1435. PubMed ID: 30132782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gram-negative bacterial sepsis and sepsis syndrome.
    Dunn DL
    Surg Clin North Am; 1994 Jun; 74(3):621-35. PubMed ID: 8197534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].
    Candel FJ; Martínez-Sagasti F; Borges M; Maseda E; Herrera-Gutiérrez M; Garnacho-Montero J; Maynar FJ; Zaragoza R; Mensa J; Azanza JR
    Rev Esp Quimioter; 2010 Sep; 23(3):115-21. PubMed ID: 20844841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.
    Vazquez-Grande G; Kumar A
    Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.
    Willatts SM; Speller DC; Winter RJ
    Anaesthesia; 1994 Sep; 49(9):751-4. PubMed ID: 7978126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.